Arbutus Biopharma
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
SIMS KAREN officer: Chief Medical Officer
Common Shares 4,358 $2.31 $10,080
Sale
HASTINGS DAVID C officer: Chief Financial Officer
Common Shares 9,593 $2.31 $22,189
Sale
SOFIA MICHAEL J. officer: Chief Scientific Officer
Common Shares 9,982 $2.31 $23,088
Sale
MCELHAUGH MICHAEL J. director, officer: Interim Pres..
Common Shares 10,164 $2.31 $23,509
Sale
SOFIA MICHAEL J. officer: Chief Scientific Officer
Common Shares 200,000 $5.09 $1,018,000
Sale
MCELHAUGH MICHAEL J. officer: Chief Business Officer
Common Stock 20,000 $5 $100,000
Sale
MCELHAUGH MICHAEL J. officer: Chief Business Officer
Common Stock 40,000 $5 $200,080
Sale
MCELHAUGH MICHAEL J. officer: Chief Business Officer
Common Stock 40,000 $5 $200,080
Sale
MCELHAUGH MICHAEL J. officer: Chief Business Officer
Common Stock 20,000 $5.01 $100,200
Option
MURRAY MARK J. director, officer: President an..
Employee Stock Option (Right to Buy) 25,000 $1.35 $33,750
Option
MURRAY MARK J. director, officer: President an..
Common Shares 25,000 $1.35 $33,750
Sale
SOFIA MICHAEL J. officer: Chief Scientific Officer
Common Shares 8,500 $9.51 $80,869
Sale
SOFIA MICHAEL J. officer: Chief Scientific Officer
Common Shares 8,500 $4.76 $40,435
Sale
SOFIA MICHAEL J. officer: Chief Scientific Officer
Common Shares 10,000 $10 $100,000
Sale
SOFIA MICHAEL J. officer: Chief Scientific Officer
Common Shares 10,000 $8.91 $89,060
Sale
SOFIA MICHAEL J. officer: Chief Scientific Officer
Common Shares 10,000 $8.91 $89,060
Sale
SOFIA MICHAEL J. officer: Chief Scientific Officer
Common Shares 10,000 $8.4 $84,000
Sale
SOFIA MICHAEL J. officer: Chief Scientific Officer
Common Shares 10,000 $8.4 $84,000
Option
MURRAY MARK J. director, officer: President an..
Employee Stock Option (Right to Buy) 27,007 $0.35 $9,560
Option
MURRAY MARK J. director, officer: President an..
Common Shares 27,007 $0.35 $9,560
Purchase
DEXXON HOLDINGS LTD. other: See remarks
Series A Participating Convertible Preferred Shares 664,000 $100 $66,400,000
Purchase
VIKING GLOBAL INVESTORS LP other: Former 10% Owner
Series A Participating Convertible Preferred Shares 664,000 $100 $66,400,000
Purchase
VIKING GLOBAL PERFORMANCE LLC other: Former 10% Owner
Series A Participating Convertible Preferred Shares 664,000 $100 $66,400,000
Purchase
MACHADO PATRICK other: Former 10% Owner
Series A Participating Convertible Preferred Shares 664,000 $100 $66,400,000
Purchase
LO ANDREW other: Former 10% Owner
Series A Participating Convertible Preferred Shares 664,000 $100 $66,400,000
Purchase
SVF INVESTMENTS (UK) LTD other: Former 10% Owner
Series A Participating Convertible Preferred Shares 664,000 $100 $66,400,000
Purchase
QVT ASSOCIATES GP LLC director, 10 percent owner, oth..
Series A Participating Convertible Preferred Shares 664,000 $100 $66,400,000
Purchase
ROIVANT SCIENCES LTD. 10 percent owner
Series A Participating Convertible Preferred Shares 664,000 $100 $66,400,000
Purchase
DEXXON HOLDINGS LTD. other: See remarks
Series A Participating Convertible Preferred Shares 500,000 $100 $50,000,000
Purchase
VIKING GLOBAL INVESTORS LP other: Former 10% Owner
Series A Participating Convertible Preferred Shares 500,000 $100 $50,000,000
Purchase
VIKING GLOBAL PERFORMANCE LLC other: Former 10% Owner
Series A Participating Convertible Preferred Shares 500,000 $100 $50,000,000
Purchase
MACHADO PATRICK other: Former 10% Owner
Series A Participating Convertible Preferred Shares 500,000 $100 $50,000,000
Purchase
LO ANDREW other: Former 10% Owner
Series A Participating Convertible Preferred Shares 500,000 $100 $50,000,000
Purchase
SVF INVESTMENTS (UK) LTD other: Former 10% Owner
Series A Participating Convertible Preferred Shares 500,000 $100 $50,000,000
Purchase
QVT ASSOCIATES GP LLC director, 10 percent owner, oth..
Series A Participating Convertible Preferred Shares 500,000 $100 $50,000,000
Purchase
ROIVANT SCIENCES LTD. 10 percent owner
Series A Participating Convertible Preferred Shares 500,000 $100 $50,000,000
Sale
SOFIA MICHAEL J. officer: Chief Scientific Officer
Common Shares 10,000 $8 $80,000
Sale
SOFIA MICHAEL J. officer: Chief Scientific Officer
Common Shares 30,000 $3.71 $111,390
Option
ABRAMS MICHAEL J. officer: Managing Director
Employee Stock Option (Right to Buy) 675 $0.35 $234
Option
ABRAMS MICHAEL J. officer: Managing Director
Common Shares 14,178 $0.35 $4,906
Option
ABRAMS MICHAEL J. officer: Managing Director
Common Shares 17,044 N/A N/A
Option
ABRAMS MICHAEL J. officer: Managing Director
Employee Stock Option (right to buy) 17,044 N/A N/A
Option
MURRAY MARK J. director, officer: President an..
Employee Stock Option (right to buy) 219,428 N/A N/A
Option
MURRAY MARK J. director, officer: President an..
Common Shares 219,428 N/A N/A
Purchase
HENRIQUES RICHARD C JR director
Common Shares 1,000 $6.95 $6,950

Showing 1 to 45 of 45 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.